OpenAI acquires Orchestra Bio to bring AI to life sciences R&D

OpenAI is acquiring Orchestra Bio to integrate AI into life sciences research and development. The move aims to help biopharma teams accelerate drug development and advance new treatments. This acquisition marks OpenAI's entry into the biopharma AI sector.